AltruBio

Drug Discovery · San Francisco, CA · Founded 2000 · Privately Held (backing)

Developer of first-in-class immune-modulators to target diseases of the immune system. AltruBio is based in San Francisco, CA and was founded in 2000. It has raised $337 million across 1 recorded round; the latest was a $225 million Series B in May 2024.

Last price · $/share
—
Implied valuation
—
Total raised
$336.6M
Last round
Later Stage VC (Series B)
May 2024
Valuation — not yet established

No valuation for AltruBio is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($336.6M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of AltruBio with a free account
  • ·Watch AltruBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

AltruBio funding history

1 rounds
DateRoundRaisedPost-money
May 2024Later Stage VC (Series B)$225.0M▮
Unlock post-money valuations

Membership and data by Private Market View

How much has AltruBio raised?

AltruBio has raised $337 million in total; 1 of its rounds is on record. The largest on record was a $225 million Series B in May 2024.

How AltruBio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For AltruBio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about AltruBio

How much has AltruBio raised?
AltruBio has raised $336.6M in total funding across 1 recorded rounds.
When did AltruBio last raise?
AltruBio last raised in May 2024 (Later Stage VC (Series B)), raising $225.0M.